Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284 [Phase 1]

View source ↗

Summary

Phase 1 trial comparing pharmacokinetics and safety profiles of two investigational agents, AD-228B and AD-2284. The study is currently recruiting in individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AD-2284
  • AD-228B

Snippet

Sponsor: Addpharma Inc. | Conditions: Primary Hypercholesterolaemia | Phase 1 | Status: RECRUITING